Reporter July 29 2022

Targeted cancer drug during pregnancy

Aug. 2, 2022—The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians.

H. pylori and lung cancer

Aug. 1, 2022—Specific biomarkers for H. pylori — a bacterium that infects the stomach — were associated with increased risk of lung cancer, Vanderbilt researchers have discovered.

Video vital for telehealth visits

Jul. 28, 2022—Vanderbilt study of 18,130 telehealth visits at the beginning of the COVID-19 pandemic defines risk factors associated with telehealth access and suggests how health systems can improve access.

Specialty pharmacists help reduce MS relapse risk

Jul. 28, 2022—Just one-third of patients with relapsing multiple sclerosis remain on disease-modifying therapy, and specialty pharmacists are in a unique position to help coordinate therapy discontinuation or change and reduce the risk of relapse.

First-year School of Medicine student Aamina Dandy puts on her white coat at last week’s ceremony as Jeff Balser, MD, PhD, and Amy Fleming, MD, look on.

White Coat Ceremony marks start of medical school journey

Jul. 28, 2022—Vanderbilt University School of Medicine welcomed 96 first-year students on Friday, July 22, during its annual White Coat Ceremony.

C. difficile may contribute to colorectal cancer: study

Jul. 28, 2022—A Vanderbilt study found that the bacterium Clostridioides difficile (C. difficile) may be a previously unrecognized contributor to colorectal cancer.

Study to evaluate nasal flu vaccine for children

Jul. 28, 2022—Pediatricians with the Vanderbilt Vaccine Research Program are looking for healthy infants and children (6 months – 8 years of age) to take part in a nasal influenza vaccine study.

Marsha Eastridge is doing well following the surgical procedures she received at Vanderbilt.

Patient doing well after complex vascular procedures

Jul. 28, 2022—Marsha Eastridge had no clue she had heart problems until she was diagnosed in December 2021. Barely three weeks later, she was undergoing the first of two complex vascular procedures at Vanderbilt Heart and Vascular Institute that would save her life.